Replies to post #2879 on CardioVascular BioTherapeutics (fka CVBT)

[JBDC]

I believe this is a big deal for VT, particularly as it has the IP protection around it. In the most recent presentation from VT it has a statement from Chairman of the Board of Directors, Novo Nordisk as follows:-

Patents at the Core: the Biotech Business
World Intellectual Property Organisation - WIPO
“Anyone, I would imagine, who has tried
to create a biotech company knows just how important patents are. You learn this when you’re studying, and again at your first job, and if you haven’t done so before, you realize it the first time you
meet potential investors.”
Mads Øvlisen, Chairman of the Board of
Directors, Novo Nordisk

I would like to share the presentation with y'all but as I signed an NDA before they would send it to me, I need to check out whether I'd get into trouble for sending a link to it here.
I hope everyone has a great weekend.